Mechanisms of Resistance to Targeted Therapies for Relapsed or Refractory Acute Myeloid Leukemia. Kropp EM, Li Q. Exp Hematol 2022 Apr 10. pii: S0301-472X(22)00133.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kropp EM, Li Q. Mechanisms of Resistance to Targeted Therapies for Relapsed or Refractory Acute Myeloid Leukemia. Exp Hematol 2022 Apr 10. pii: S0301-472X(22)00133.
PMID: 35417742